Atypical Femoral Fractures Following Use of Intravenous Zoledronic Acid After Prior Treatment with Alendronate: A Clinical Practice Series and Opinion

Abstract

Aims: An increasing number atypical femoral fractures (AFFs) have been reported in patients who have taken bisphosphonates (BPs) for several years. The European Medicines Agency (EMA) concluded in 2011 that these fractures were a class effect of the drugs. The United States Food & Drug Administration (FDA) updated labels for currently proprietary intravenous Reclast™ (zoledronic acid) have, since 2015, agreed with the EMA opinion. Section 17 of the FDA label states Reclast™ “can cause” these fractures. In this report, we present a clinical sub-class of cases of these fractures illustrating the potential for harm associated with switching BP therapy from an oral agent to Reclast™ (zoledronic acid). Methodology: This paper presents 6 long-term case descriptions of patients, diagnosed with either osteopenia or osteoporosis, incurring a total of ten AFFs following a switch to intravenous zoledronic acid after a much longer and uncomplicated period on oral BPs. One additional case is presented to illustrate that AFFs may also occur with intravenous therapy alone. We have collected these cases directly from the patients and have confirmed all of the details by access to the original medical records, including the radiology and surgery reports. Our opportunity for access is fully described in the article. Results and Opinion: Such a switch has never been investigated in a clinical trial. Based on the pharmacokinetics associated with the intravenous routes for these drugs, we present our reasoning why the untested therapy exemplified should be considered as potentially hazardous. Furthermore, we discuss the reported but rather unremarked wide individual variation in the rate of elimination of intravenously-administered BPs which may be an important factor in determining which individuals are at greatest risk of incurring an AFF.

Authors and Affiliations

W. Banks Hinshaw, Jennifer P. Schneider

Keywords

Related Articles

Prolonged Impacted Denture in the Esophagus Mimicking Gastroesophageal Reflux Disease: Case Report

Accidental ingestion of denture resulting in esophageal impaction is fairly reported in the literature. It is, however, uncommon to find such impaction lasting more than a few days without the development of serious comp...

Huge Left Ventricular Aneurysm in a Young Patient Diagnosed with a 4 Slice CT Scanner at University of Gondar Hospital; a Case Report and Review of Literature

A case of huge left ventricular aneurysm of submitral type in a 21 year old Ethiopian patient is presented. This rare type of LVA is reported in young black Africans in Nigeria and South Africa but never in East Africa....

Low Residue Diet & Codeine May Substitute Faecal Diversion in Conservative Management of Patient with Rectourethral Fistula - A Case Report

Aims: We present a patient that developed rectourethral fistula following prostatectomy for a misdiagnosed prostate cancer. He was managed conservatively without faecal diversion. Case Presentation: A 65 year old man pr...

Bracket Assisted Treatment of Multiple Gingival Recession Using Placental Membrane- A One Year Follow up Case Series

Gingival recession is the apical migration of the junctional epithelium with exposure of the root surface. The treatment of buccal gingival recession is a common requirement due to esthetic concern or root sensitivity. S...

Successful Medical Treatment of Haemorrhagic Cystitis in a Dog

Aims: To evaluate the aetiology and medical treatment of haemorrhagic cystitis in a nine-month-old Caucasian dog. Place and Duration of Study: The study was carried out in the Veterinary Teaching Hospital, Michael Okpara...

Download PDF file
  • EP ID EP310531
  • DOI 10.9734/IJMPCR/2017/36791
  • Views 88
  • Downloads 0

How To Cite

W. Banks Hinshaw, Jennifer P. Schneider (2017). Atypical Femoral Fractures Following Use of Intravenous Zoledronic Acid After Prior Treatment with Alendronate: A Clinical Practice Series and Opinion. International Journal of Medical and Pharmaceutical Case Reports, 10(2), 1-11. https://europub.co.uk./articles/-A-310531